“…Indeed, it has been reported that it is important to modify the pathways that initiate resolution processes, including efferocytosis, by M2-like macrophages to treat chronic inflammatory pathology ( Fullerton and Gilroy, 2016 ). Interestingly, IL-34 shows tissue-specific expression in the skin and is downregulated in sun-exposed skin of individuals in their age 60s, and a previous report indicated that the expression of IL-34 in sun-protected skin does not change with aging, suggesting that the IL-34 downregulation‒mediated increase in the M1-to-M2 ratio with aging may be a specific pathway in the skin, especially in sun-exposed areas ( Baghdadi et al., 2018 ; Carithers et al., 2015 ; Hasegawa et al., 2020 ). Therefore, aging-related downregulation of IL-34 in keratinocytes may explain the increase in the M1-to-M2 ratio and constitutes a possible mechanism underlying the accelerated inflammaging of sun-exposed skin.…”